Filtros : "Pharmaceutical Development and Technology" Removido: "2015" Limpar

Filtros



Limitar por data


  • Fonte: Pharmaceutical Development and Technology. Unidade: FCF

    Assuntos: PELE, AZEITE

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MOTA, Ana Henriques et al. Design and evaluation of novel topical formulation with olive oil as natural functional active. Pharmaceutical Development and Technology, v. 23, n. 8, p. 794-805, 2018Tradução . . Disponível em: https://doi.org/10.1080/10837450.2017.1340951. Acesso em: 28 nov. 2025.
    • APA

      Mota, A. H., Silva, C. O., Nicolai, M., Baby, A. R., Palma, L., Rijo, P., et al. (2018). Design and evaluation of novel topical formulation with olive oil as natural functional active. Pharmaceutical Development and Technology, 23( 8), 794-805. doi:10.1080/10837450.2017.1340951
    • NLM

      Mota AH, Silva CO, Nicolai M, Baby AR, Palma L, Rijo P, Ascensão L, Reis CP. Design and evaluation of novel topical formulation with olive oil as natural functional active [Internet]. Pharmaceutical Development and Technology. 2018 ; 23( 8): 794-805.[citado 2025 nov. 28 ] Available from: https://doi.org/10.1080/10837450.2017.1340951
    • Vancouver

      Mota AH, Silva CO, Nicolai M, Baby AR, Palma L, Rijo P, Ascensão L, Reis CP. Design and evaluation of novel topical formulation with olive oil as natural functional active [Internet]. Pharmaceutical Development and Technology. 2018 ; 23( 8): 794-805.[citado 2025 nov. 28 ] Available from: https://doi.org/10.1080/10837450.2017.1340951
  • Fonte: Pharmaceutical Development and Technology. Unidades: EP, FCF

    Assuntos: COMPRIMIDOS, CELULOSE, FÁRMACOS

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DUQUE, Marcelo Dutra et al. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design. Pharmaceutical Development and Technology, v. 18, n. 5, p. 1247-1254, 2013Tradução . . Disponível em: https://doi.org/10.3109/10837450.2012.693508. Acesso em: 28 nov. 2025.
    • APA

      Duque, M. D., Kreidel, R. N., Taqueda, M. E. S., Baby, A. R., Kaneko, T. M., Velasco, M. V. R., & Consiglieri, V. O. (2013). Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design. Pharmaceutical Development and Technology, 18( 5), 1247-1254. doi:10.3109/10837450.2012.693508
    • NLM

      Duque MD, Kreidel RN, Taqueda MES, Baby AR, Kaneko TM, Velasco MVR, Consiglieri VO. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design [Internet]. Pharmaceutical Development and Technology. 2013 ; 18( 5): 1247-1254.[citado 2025 nov. 28 ] Available from: https://doi.org/10.3109/10837450.2012.693508
    • Vancouver

      Duque MD, Kreidel RN, Taqueda MES, Baby AR, Kaneko TM, Velasco MVR, Consiglieri VO. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design [Internet]. Pharmaceutical Development and Technology. 2013 ; 18( 5): 1247-1254.[citado 2025 nov. 28 ] Available from: https://doi.org/10.3109/10837450.2012.693508

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2025